| 臺大學術典藏 |
2021-06-29T03:58:33Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Chia-Chun Wang; Tsai C.-L.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-25T08:49:27Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
YUN CHIANG; Cheng J.C.-H.; Huang C.-Y.; Tsai Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-06-25T08:49:26Z |
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
|
Tien Y.; Tsai C.-L.; Hou W.-H.; YUN CHIANG; Hsu F.-M.; Tsai Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-25T07:21:53Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; YU-FENG LIN; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-06-03T06:50:21Z |
Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children
|
HSIANG-PO HUANG; Hsu H.-Y.; Chen C.-L.; Ni Y.-H.; Wang H.-Y.; Tsuei D.-J.; Chiang C.-L.; Tsai Y.-C.; Chen H.-L.; Chang M.-H. |
| 臺大學術典藏 |
2021-05-31T06:17:57Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; MING-JAI SU; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:55Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; Tsai Y.-C.; Pu Y.-S.; CHIH-KANG CHIANG; Liu S.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:41Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.;Kuo K.-L.;Liu S.-H.-.;Chang H.-C.;Hsieh J.-T.;Wu J.-T.;Chih-Kang Chiang;Lin W.-C.;Tsai Y.-C.;Chou C.-T.;Hsu C.-H.;Pu Y.-S.;Shi C.-S.;Huang K.-H.; Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; CHIH-KANG CHIANG; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-05-27T09:06:39Z |
Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy
|
Lee W.-J.;Liu S.-H.;Chih-Kang Chiang;Lin S.-Y.;Liang K.-W.;Chen C.-H.;Tien H.-R.;Chen P.-H.;Wu J.-P.;Tsai Y.-C.;Lai D.-W.;Chang Y.-C.;Sheu W.H.-H.;Sheu M.-L.; Lee W.-J.; Liu S.-H.; CHIH-KANG CHIANG; Lin S.-Y.; Liang K.-W.; Chen C.-H.; Tien H.-R.; Chen P.-H.; Wu J.-P.; Tsai Y.-C.; Lai D.-W.; Chang Y.-C.; Sheu W.H.-H.; Sheu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:21:01Z |
Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy
|
Tsai Y.-C.; CHEN-HUA LIU; Liao C.-H.; Chen M.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-05-21T07:17:50Z |
Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer
|
CHIAO-LING TSAI; Wu J.-K.; Chao H.-L.; Tsai Y.-C.; Cheng J.C.H. |
| 臺大學術典藏 |
2021-05-21T07:17:48Z |
Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: A planning and feasibility study
|
Tsai Y.-C.; CHIAO-LING TSAI; Hsu F.-M.; Jian-Kuen W.; Chien-Jang W.; Cheng J.C.H. |
| 臺大學術典藏 |
2021-05-21T07:17:46Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; CHIAO-LING TSAI; Tsai Y.-C.; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-05-21T07:17:43Z |
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
|
Tien Y.; CHIAO-LING TSAI; Hou W.-H.; Chiang Y.; Hsu F.-M.; Tsai Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-05-18T08:25:08Z |
How to start your monocot CRISPR/Cas project: plasmid design, efficiency detection, and offspring analysis
|
Yue, J.-J.;Hong, C.-Y.;Wei, P.;Tsai, Y.-C.;Lin, C.-S.; Yue, J.-J.; Hong, C.-Y.; Wei, P.; Tsai, Y.-C.; Lin, C.-S.; CHWAN-YANG HONG; YU-CHANG TSAI |
| 臺大學術典藏 |
2021-05-18T08:25:03Z |
H2O2-based method for rapid detection of transgene-free rice plants from segregating CRISPR/Cas9 genome-edited progenies
|
Wu, T.-M.;Huang, J.-Z.;Oung, H.-M.;Hsu, Y.-T.;Tsai, Y.-C.;Hong, C.-Y.; Wu, T.-M.; Huang, J.-Z.; Oung, H.-M.; Hsu, Y.-T.; Tsai, Y.-C.; Hong, C.-Y.; CHWAN-YANG HONG; YU-CHANG TSAI |
| 臺大學術典藏 |
2021-05-12T03:27:17Z |
A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study
|
Tai T.-T.; Wu T.-J.; HUEY-DONG WU; Tsai Y.-C.; Wang H.-T.; Wang A.-M.; Shih S.-F.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-06T08:30:56Z |
Systematic review and network meta-analysis of immune checkpoint inhibitors in combination with chemotherapy as a first-line therapy for extensive-stage small cell carcinoma
|
Chen H.-L.;Yu-Kang Tu;Chang H.-M.;Lee T.-H.;Wu K.-L.;Tsai Y.-C.;Lee M.-H.;Yang C.-J.;Hung J.-Y.;Chong I.-W.; Chen H.-L.; YU-KANG TU; Chang H.-M.; Lee T.-H.; Wu K.-L.; Tsai Y.-C.; Lee M.-H.; Yang C.-J.; Hung J.-Y.; Chong I.-W. |
| 臺大學術典藏 |
2021-05-06T01:51:42Z |
A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study
|
Tai T.-T.; Wu T.-J.; Wu H.-D.; Tsai Y.-C.; Wang H.-T.; Wang A.-M.; Shih S.-F.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-05-04T06:41:38Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
Chen J.L.-Y.; Chen J.-P.; YU-SEN HUANG; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2021-04-30T07:26:54Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
JENNY LING-YU CHEN; Chen J.-P.; Huang Y.-S.; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2021-04-30T07:26:53Z |
Prominin-1-Specific Binding Peptide-Modified Apoferritin Nanoparticle Carrying Irinotecan as a Novel Radiosensitizer for Colorectal Cancer Stem-Like Cells
|
JENNY LING-YU CHEN; Tsai Y.-C.; Tsai M.-H.; Lee S.-Y.; Wei M.-F.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:56Z |
FDG PET manifestation of lobular panniculitis
|
Yen R.-F.; Shun C.-T.; Pan M.-H.; Tsai Y.-C.; YEN-WEN WU |
| 臺大學術典藏 |
2021-03-18T08:54:56Z |
Aortic Dissection Detected on Three-Phase Bone Scintigraphy
|
Yen R.-F.; Pan M.-H.; Tsai Y.-C.; YEN-WEN WU |
| 臺大學術典藏 |
2021-03-18T05:59:06Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; KAI-YUAN TZEN; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:01Z |
Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells
|
Tsai Y.-C.; Ho P.-Y.; KAI-YUAN TZEN; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-18T02:03:22Z |
FDG PET manifestation of lobular panniculitis
|
Yen R.-F.;Chia-Tung Shun;Pan M.-H.;Tsai Y.-C.;Wu Y.-W.; Yen R.-F.; CHIA-TUNG SHUN; Pan M.-H.; Tsai Y.-C.; Wu Y.-W. |
| 臺大學術典藏 |
2021-03-18T02:03:05Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Chia-Tung Shun;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Pu Y.-S.; Chen C.-H.; CHIA-TUNG SHUN; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-18T02:02:51Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; CHIA-TUNG SHUN; Hee S.-W.; Chang Y.-C.; Tsai Y.-C.; Tsai J.-S.; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
| 臺大學術典藏 |
2021-03-18T02:02:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-18T02:02:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-16T02:43:09Z |
Current and future aspect of immunotherapy for advanced renal cell carcinoma
|
FU-JEN HSUEH; Tsai Y.-C. |
| 臺大學術典藏 |
2021-03-10T07:51:13Z |
Development of a nano-immunomodulator encapsulating R837 and caffeine for combined radio-/immunotherapy against orthotopic breast cancer
|
YING-CHIEH YANG; Liu, T.-I. ; Tsai, Y.-C. ; Wang, T.-M. ; Chang, S.-H. ; Chen, H.-H. ; Chiu, H.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Tsai Y.-C.;Wu C.-T.;Ruey-Long Hong; Tsai Y.-C.; Wu C.-T.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-04T06:45:06Z |
Assessing the Profitability of Timely Opening Range Breakout on Index Futures Markets
|
Tsai, Y.-C.; Wu, M.-E.; Syu, J.-H.; Lei, C.-L.; Wu, C.-S.; Ho, J.-M.; Wang, C.-J.; CHIN-LAUNG LEI |
| 臺大學術典藏 |
2021-02-23T08:26:22Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
Chen J.L.-Y.; Chen J.-P.; Huang Y.-S.; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2021-02-23T08:26:18Z |
Prominin-1-Specific Binding Peptide-Modified Apoferritin Nanoparticle Carrying Irinotecan as a Novel Radiosensitizer for Colorectal Cancer Stem-Like Cells
|
Chen J.L.-Y.;Tsai Y.-C.;Tsai M.-H.;Lee S.-Y.;Wei M.-F.;Sung-Hsin Kuo;Shieh M.-J.; Chen J.L.-Y.; Tsai Y.-C.; Tsai M.-H.; Lee S.-Y.; Wei M.-F.; SUNG-HSIN KUO; Shieh M.-J. |
| 臺大學術典藏 |
2021-02-04T02:30:35Z |
Intraventricular Medium B Treatment Benefits an Ischemic Stroke Rodent Model via Enhancement of Neurogenesis and Anti-apoptosis
|
Chen, Y.-A.;Tsai, Y.-C.;Chen, Y.-D.;Liu, D.-Z.;Young, T.-H.;Tsai, L.-K.Tai-Horng Young; Chen, Y.-A.; Tsai, Y.-C.; Chen, Y.-D.; Liu, D.-Z.; Young, T.-H.; Tsai, L.-K.; TAI-HORNG YOUNG |
| 臺大學術典藏 |
2021-02-04T02:30:31Z |
Magnetic micro sensors with two magnetic field effect transistors fabricated using the commercial complementary metal oxide semiconductor process
|
Chen, W.-R.;Tsai, Y.-C.;Shih, P.-J.;Hsu, C.-C.;Dai, C.-L.Po-Jen Shih; Chen, W.-R.; Tsai, Y.-C.; Shih, P.-J.; Hsu, C.-C.; Dai, C.-L.; PO-JEN SHIH |
| 臺大學術典藏 |
2021-02-04T02:30:31Z |
Low-concentration ammonia gas sensors manufactured using the CMOS-MEMS technique
|
Shen, W.-C.;Shih, P.-J.;Tsai, Y.-C.;Hsu, C.-C.;Dai, C.-L.Po-Jen Shih; Shen, W.-C.; Shih, P.-J.; Tsai, Y.-C.; Hsu, C.-C.; Dai, C.-L.; PO-JEN SHIH |
| 臺大學術典藏 |
2021-02-04T02:30:26Z |
Predictive factors of post-laparoscopic inguinal hernia acute and chronic pain: prospective follow-up of 807 patients from a single experienced surgeon
|
Lo, C.-W.;Chen, Y.-T.;Jaw, F.-S.;Yu, C.-C.;Tsai, Y.-C.Fu-Shan Jaw; Lo, C.-W.; Chen, Y.-T.; Jaw, F.-S.; Yu, C.-C.; Tsai, Y.-C.; FU-SHAN JAW |
| 臺大學術典藏 |
2021-02-02T00:46:57Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:57Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:56Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Yeong-Shiau Pu; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:50Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; Tsai Y.-C.; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:47Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:46:39Z |
Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.
|
YEONG-SHIAU PU; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; Tsai Y.C.; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-02-02T00:46:36Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; Tsai Y.-C.; YEONG-SHIAU PU; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:32Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Tsai Y.-C.; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:21Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Chang H.-C.;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Yeong-Shiau Pu;Huang K.-H.; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU; Huang K.-H. |
